1. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
    Shayista Akbar et al, 2023, Front. Immunol. CrossRef
  2. The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and with tumor resident, adaptive immune receptor features
    Jacob C Kinskey et al, 2023 CrossRef
  3. Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
    Joe Q. Wei et al, 2023, Biomedicines CrossRef
  4. Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer
    Yuan Yao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  5. Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint Inhibitor
    Chien-Yu Chou et al, 2023, ACS Omega CrossRef
  6. IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
    Yuki Azumi et al, 2023, Cells CrossRef
  7. M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
    Ryota Sumitomo et al, 2023, Cancer Science CrossRef
  8. PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer
    Giedrė Gurevičienė et al, 2024, Medicina CrossRef
  9. Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity
    Xizi Hu et al, 2024, J Immunother Cancer CrossRef
  10. Decoding the complex web: Cellular and molecular interactions in the lung tumor microenvironment
    Bahjat Saeed Issa et al, 2024, Journal of Drug Targeting CrossRef
  11. Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
    Sarra Mestiri et al, 2025, Cancer Metastasis Rev CrossRef